Industries

Life Sciences & Biotechnology

In 1980, a Supreme Court ruling¹ opened the floodgates in life sciences patenting; and the biotechnology industry has never looked back. Indeed, the excitement and promise of the industry grow year to year as more sophisticated tools are developed and more ambitious research programs—such as quickly and cheaply sequencing genomes—come within our power to accomplish.

At Amster, Rothstein & Ebenstein LLP, we have participated from the start in obtaining suitable protection for our clients’ valuable biotechnology discoveries and inventions:

• We counsel start-ups and early phase companies on their IP strategy and course of development.
• We can assess your firm’s biotech IP inventory and help you maximize the value of your overall portfolio.
• Where necessary, we have the skilled and courtroom-savvy litigation attorneys who can assert and defend contested patents at trial and on appeal.

Developments in life sciences and biotechnology are coming at an ever more rapid rate, many embodying techniques, procedures, or discoveries unimaginable just a few short years ago, such as individually tailored genetic therapies.

The value of these cutting-edge techniques—both to the patients whose lives are aided by them, and to your firm as a reward for developing them—can be very high.

Your biotech IP assets deserve the most thoughtful and sophisticated protection. Talk to us.

¹ DIAMOND v. CHAKRABARTY, 447 U.S. 303 (1980)